Back to Search
Start Over
Concentration levels of IL-10 and TNF α cytokines in patients with human papilloma virus (HPV) DNA+ and DNA− cervical lesions.
- Source :
- Journal of Immunotoxicology; Jun2012, Vol. 9 Issue 2, p168-172, 5p
- Publication Year :
- 2012
-
Abstract
- The present study was performed to assess the immune response in women with human papilloma virus (HPV) DNA<superscript>+</superscript> and DNA<superscript>−</superscript> cervical lesions. Eighty women with cervical lesions (age range = 25-70 years) and 20 healthy individuals (control group) were enrolled in the study. Lesions were cytologically classified into four groups: ASC-US (20), CINI (30), CINII-III (16), and cervical carcinoma (14) prior to HPV DNA detection. Estimation of interleukin (IL)-10 and tumor necrosis factor (TNF)- α levels in cervical secretions and serum of the studied patients was performed utilizing ELISA. PCR screening kits were used to detect HPV DNA in cervical smears obtained from the studied cases with the different lesions. IL-10 levels in cervical secretions of HPV DNA<superscript>+</superscript> were significantly greater than those from DNA<superscript>−</superscript> patients (i.e., 88.73 vs 24.00 pg/ml) and from controls (i.e., 88.73 vs 8.27 pg/ml) and the levels were higher in DNA<superscript>−</superscript> patients than in controls (i.e., 24.00 vs 8.27 pg/ml). In comparison, serum IL-10 levels in these patients did not significantly differ from control values (i.e., 13.69 vs 12.16 vs 9.99 pg/ml, respectively). TNF α levels in cervical secretions of the HPV DNA<superscript>+</superscript> and DNA<superscript>−</superscript> cases did not significantly differ from values for the controls (i.e., 12.18 vs 9.90 vs 7.90 pg/ml, respectively). Serum TNF α of these patients also did not differ significantly from controls (i.e., 11.59 vs 11.90 vs 10.83 pg/ml, respectively). The detected levels of IL-10 in cervical secretions of patients with HPV DNA<superscript>+</superscript> lesions was significantly higher than in their sera, while secretion TNF α levels were nominally greater than sera values. Lastly, higher levels of IL-10 were observed in secretions of 10-14 (71.4%) patients who had progressive cervical lesions (HSIL and cervical cancer stages) who were HPV DNA<superscript>+</superscript> than observed in 20 of 66 (30.0%) of DNA<superscript>−</superscript> patients with similar progressive lesions. In general, the higher levels of IL-10 than of TNF α suggested a potential down-modulation of tumor-specific immune responses to HPV-infected lesions. This phenomenon appears to provide a tumor 'progressive' microenvironment in these particular patients. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 1547691X
- Volume :
- 9
- Issue :
- 2
- Database :
- Complementary Index
- Journal :
- Journal of Immunotoxicology
- Publication Type :
- Academic Journal
- Accession number :
- 75162849
- Full Text :
- https://doi.org/10.3109/1547691X.2011.642419